Cargando…
Comparison of SARS-CoV-2 virus detection using the Xpert Xpress rapid molecular test on Abbott M2000 Real-Time System: a cross-sectional study
Emergency use of molecular rapid test kits approved by the Food and Drug Administration (FDA) includes the Xpert Xpress SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) kit. The rapid molecular test is one of the examinations using the reverse transcription-polymerase chain reaction (RT-...
Autores principales: | Hasanah, Miftah, Aulia, Fauqa Arinil, Wardhani, Puspa, Aryati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289558/ https://www.ncbi.nlm.nih.gov/pubmed/37363578 http://dx.doi.org/10.1097/MS9.0000000000000802 |
Ejemplares similares
-
Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2020) -
Rapid Evaluation of the Xpert(®) Xpress CoV-2 plus and Xpert(®) Xpress CoV-2/Flu/RSV plus Tests
por: Noble, Lara Dominique, et al.
Publicado: (2022) -
Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs
por: Serei, Virian D., et al.
Publicado: (2021) -
Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay
por: Graham, Maryza, et al.
Publicado: (2021) -
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
por: Loeffelholz, Michael J., et al.
Publicado: (2020)